The Effects Assessment of the Polygonatum Kingianum Extract on Endurance Performance and Anti-fatigue

NCT ID: NCT05877677

Last Updated: 2023-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-18

Study Completion Date

2023-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the efficacy of polygonatum kingianum extract on endurance performance and anti-fatigue

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo drink

consume 1 bottle per day

Group Type PLACEBO_COMPARATOR

Placebo drink

Intervention Type DIETARY_SUPPLEMENT

consume 1 bottle per day

Polygonatum kingianum extract drink

consume 1 bottle per day

Group Type EXPERIMENTAL

Polygonatum kingianum extract drink

Intervention Type DIETARY_SUPPLEMENT

consume 1 bottle per day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo drink

consume 1 bottle per day

Intervention Type DIETARY_SUPPLEMENT

Polygonatum kingianum extract drink

consume 1 bottle per day

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Dragon Power® Polygonatum kingianum extract drink

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy male aged 30-60 years old
* Must read and sign the informed consent form
* During the experiment, do not change the lifestyle and eating habits
* Cooperate not to engage in high-intensity exercise 48 hours before each experiment

Exclusion Criteria

* Subject who is not willing to participate in this study.
* People with serious diseases of heart, liver, kidney, endocrine and other organs (such as hypertension, diabetes, renal dysfunction and heart-related diseases) and mental patients
* People who have undergone surgery within 6 months or have lower limb injuries
* People who are allergic to Polygonatum kingianum extract
* Participate in other clinical trials related to anti-fatigue within four weeks of the trial
* Students who are currently taking courses taught by the principal investigator of this trial.
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TCI Co., Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bo-han Wu

Role: PRINCIPAL_INVESTIGATOR

National Pingtung University of Science and Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Pingtung University of Science and Technology

Pingtung City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-027-A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.